Re: Aducanumab-Related ARIA: Paean or Lament?: Erratum : Clinical Nuclear Medicine

Secondary Logo

Journal Logo

Erratum

Re: Aducanumab-Related ARIA: Paean or Lament?: Erratum

Clinical Nuclear Medicine 48(4):p 380, April 2023. | DOI: 10.1097/RLU.0000000000004624
  • Free

In the February 1, 2023 issue of Clinical Nuclear Medicine, in the article by Wassef and Colletti, “Re: Aducanumab-Related ARIA: Paean or Lament?”, the authors report an error in the beginning of the article. It begins “We appreciate Drs Høilund-Carlsen and Alavi’s interest and their kind words regarding the scope and content of our recent commentary in Clinical Nuclear Medicine” and should be “We appreciate Drs Høilund-Carlsen, Alavi, and Revheim’s interest and their kind words regarding the scope and content of our recent commentary in Clinical Nuclear Medicine.”

Reference

Wassef HR, Colletti PM. Re: Aducanumab-related ARIA: paean or lament? Clin Nucl Med. 2023;48:168–169.
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.